CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BGNE

BGB-45035

Phase 2
BeiGene, Ltd. (BGNE)

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Oct '26
BGNEPhase 2

BGB-45035 Phase 2 Est. Readout

BGB-45035
Oct 2026~
CT.gov
00%
Drug Information

Target Indication

Rheumatoid Arthritis

Clinical Trial

NCT07100938

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.